A roadmap for discovery and translation in lymphoma

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Harvard Medical School, Boston, MA.
² Institute for Cancer Genetics and Department of Pathology and Cell Biology, Columbia University, New York, NY.
³ Division of Medical Oncology and Department of Pathology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada University of British Columbia, Vancouver, BC, Canada.
⁴ Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY.
⁵ Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA.
⁶ Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
⁷ Division of Hematology, Mayo Clinic, Rochester, MN.
⁸ Hematology and Oncology Divisions, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA University of Washington, Seattle, WA.
⁹ Division of Medical Oncology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada University of British Columbia, Vancouver, BC, Canada.
¹⁰ Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

David M Weinstock et al. Blood. 2015.

. 2015 Mar 26;125(13):2175-7.

doi: 10.1182/blood-2015-01-623777.

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Harvard Medical School, Boston, MA.
² Institute for Cancer Genetics and Department of Pathology and Cell Biology, Columbia University, New York, NY.
³ Division of Medical Oncology and Department of Pathology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada University of British Columbia, Vancouver, BC, Canada.
⁴ Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY.
⁵ Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA.
⁶ Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
⁷ Division of Hematology, Mayo Clinic, Rochester, MN.
⁸ Hematology and Oncology Divisions, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA University of Washington, Seattle, WA.
⁹ Division of Medical Oncology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada University of British Columbia, Vancouver, BC, Canada.
¹⁰ Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

No abstract available

References

1. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032. - PMC - PubMed
1. Oettgen HF, Clifford P, Burkitt D. Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D. Cancer Chemother Rep. 1963;28:25–34. - PubMed
1. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–242. - PubMed
1. Rooney CM, Smith CA, Ng CY, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995;345(8941):9–13. - PubMed
1. Pescatore P, Heine M, Manegold BC. Cure of gastric lymphoma with antibiotics. Gastroenterology. 1995;109(1):334–335. - PubMed